menu search

23andme announces poster presentations on 23me-00610, an investigational antibody targeting cd200r1, at the society for immunotherapy of cancer’s (sitc) 2023 annual meeting

23andMe to present data on efficacy and safety and dose selection for the ongoing 23me-00610 Phase 1/2a...

September 27, 2023, 8:05 pm


Search within

Pages Search Results: